Distinct molecular origins for Denys-Drash and Frasier syndromes

Area of Science:

• Genetics and Molecular Biology
• Endocrinology
• Pediatric Nephrology

Background:

• Denys-Drash syndrome and Frasier syndrome are rare genetic disorders.
• Both syndromes present with streak gonads, pseudohermaphroditism, and renal failure.
• The Wilm's tumor suppressor gene (WT1) is implicated in kidney and gonad development.

Purpose of the Study:

• To investigate the role of Wilm's tumor suppressor gene (WT1) mutations in differentiating Denys-Drash syndrome and Frasier syndrome.
• To establish a molecular basis for distinguishing between these two clinically similar conditions.

Main Methods:

• Genetic analysis of Wilm's tumor suppressor gene (WT1) in patients with Denys-Drash syndrome and Frasier syndrome.
• Mutation screening focused on exons 8 and 9 of the WT1 gene.

Main Results:

• Direct involvement of Wilm's tumor suppressor gene (WT1) mutations in exons 8 or 9 was established in Denys-Drash syndrome.
• Absence of these specific WT1 alterations was observed in three patients diagnosed with Frasier syndrome.

Conclusions:

• Mutations in specific exons of the Wilm's tumor suppressor gene (WT1) serve as a molecular marker for Denys-Drash syndrome.
• The absence of these mutations helps differentiate Frasier syndrome from Denys-Drash syndrome, aiding in accurate diagnosis and management.